Free US shipping for orders above $200

https://images.powerpeptides.com/SS-31_10mg.png

SS-31

Product information

$62.99

  • Buy 3+ for $60.47 each and save 4%
  • Buy 5+ for $59.21 each and save 6%
  • Buy 10+ for $57.95 each and save 8%

Size:

SS-31 (10mg)

$ 62.99

Ships Today if ordered within 4 hrs 47 min.

Free FedEx next-day delivery within the US on orders over $200, with a tracking number provided.

Third party tested

FREE Bacteriostatic Water

For every $400 you spend, get 1 FREE bottle of Bacteriostatic Water to reconstitute your peptides.

Product description

SS-31, also known as elamipretide, is a small mitochondrially-targeted tetrapeptide that has shown promising results in various research studies for its potential therapeutic benefits. This peptide is designed to penetrate the mitochondrial membrane and protect against oxidative stress, inflammation, and mitochondrial dysfunction. SS-31 has been investigated for its neuroprotective, cardioprotective, and anti-aging properties, making it a potential candidate for the treatment of various age-related and neurodegenerative disorders.

Product Usage: This product is intended solely for use as a research chemical in vitro and laboratory experimentation by licensed, qualified professionals. It is not approved for human or animal consumption. Misuse, misbranding, or mislabeling as a drug, food, or cosmetic is strictly prohibited. All information provided is for educational purposes only.

Table of Contents

  1. Characteristics
  2. How does SS-31 work?
  3. Benefits
  4. Side Effects
  5. Summary
  6. Certificate of Analysis (COA)
  7. References

Characteristics

Molecular Formula

C₃₆H₅₆N₁₂O₈

CAS

71587876

Molar Mass

768.91 g/mol

Amino Acid Sequence

D-Arg-Dmt-Lys-Phe-NH₂

Synonyms

Elamipretide, Bendavia, MTP-131, SS 31

Solubility

Water-soluble

Organoleptic Profile

White to off-white solid

Composition

Synthetic peptide

How does SS-31 work?

SS-31 targets the inner mitochondrial membrane, where it binds to cardiolipin, a phospholipid essential for maintaining mitochondrial structure and function. By stabilizing cardiolipin, SS-31 helps to preserve the integrity of the mitochondrial membrane and enhances the efficiency of the electron transport chain. This, in turn, reduces the production of reactive oxygen species (ROS) and improves overall mitochondrial function.

Additionally, SS-31 has been shown to modulate various signaling pathways involved in inflammation, apoptosis, and cellular stress responses. It can inhibit the activation of pro-inflammatory cytokines, such as TNF-α and IL-1β, and reduce the expression of apoptotic markers, like caspase-3 and Bax. SS-31 also promotes the activation of pro-survival pathways, including the PI3K/Akt and MAPK/ERK signaling cascades, which contribute to its cytoprotective effects.

Benefits

  • Neuroprotection: SS-31 has demonstrated neuroprotective properties in various animal models of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and traumatic brain injury. It can reduce oxidative stress, inflammation, and mitochondrial dysfunction in the brain, leading to improved cognitive function and reduced neuronal damage.

  • Cardioprotection: Studies have shown that SS-31 can protect the heart from ischemia-reperfusion injury, reduce cardiac hypertrophy, and improve cardiac function in models of heart failure. By preserving mitochondrial function and reducing oxidative stress, SS-31 may have potential therapeutic applications in cardiovascular diseases.

  • Anti-aging effects: SS-31 has been investigated for its potential to attenuate age-related changes in various tissues, including the heart, skeletal muscle, and brain. It can reduce age-associated post-translational modifications of proteins, improve mitochondrial function, and enhance cellular resilience, suggesting its potential as an anti-aging intervention.

  • Mitochondrial myopathy: In a randomized clinical trial (MMPOWER-3), SS-31 demonstrated efficacy and safety in individuals with primary mitochondrial myopathy. The peptide improved exercise tolerance, walking distance, and overall quality of life in patients, highlighting its potential as a treatment for mitochondrial disorders.

  • Retinal diseases: SS-31 has shown promise in preclinical studies for the treatment of age-related macular degeneration (AMD) and other retinal disorders. By reducing oxidative stress and preserving mitochondrial function in the retina, SS-31 may help to prevent or slow the progression of these diseases.

Side Effects

In clinical trials and preclinical studies, SS-31 has been generally well-tolerated, with no significant adverse effects reported. However, as with any investigational compound, further research is needed to fully evaluate its safety profile and potential long-term side effects.

Summary

SS-31 (elamipretide) is a mitochondrially-targeted peptide that has shown promising therapeutic potential in various research studies. By stabilizing cardiolipin, reducing oxidative stress, and modulating inflammatory and apoptotic pathways, SS-31 can protect against mitochondrial dysfunction and cellular damage. Its neuroprotective, cardioprotective, and anti-aging properties make it a potential candidate for the treatment of age-related and neurodegenerative disorders, as well as mitochondrial myopathies and retinal diseases. While further clinical studies are needed to fully evaluate its efficacy and safety, SS-31 represents an exciting avenue for the development of novel therapies targeting mitochondrial dysfunction.

References

  1. Obi C, Smith AT, Hughes GJ, Adeboye AA. Targeting mitochondrial dysfunction with elamipretide. Heart Fail Rev. 2022

  2. Nhu NT, Xiao SY, Liu Y, Kumar VB, Cui ZY, Lee SD. Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration. Front Integr Neurosci. 2022

  3. Jiang W, He F, Ding G, Wu J. Elamipretide reduces pyroptosis and improves functional recovery after spinal cord injury. CNS Neurosci Ther. 2023

  4. Sabbah HN. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide. Heart Fail Rev. 2021

  5. Nashine S. Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD). Cells. 2021

  6. Chatfield KC, Sparagna GC, Chau S, Phillips EK, Ambardekar AV, Aftab M, Mitchell MB, Sucharov CC, Miyamoto SD, Stauffer BL. Elamipretide Improves Mitochondrial Function in the Failing Human Heart. JACC Basic Transl Sci. 2019

  7. Zuo Y, Yin L, Cheng X, Li J, Wu H, Liu X, Gu E, Wu J. Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice. Front Cell Neurosci. 2020

Why Power Peptides is the best place to buy SS-31

Power Peptides™ is more than just a trusted U.S. supplier of research peptides. We are a catalyst for scientific advancement, dedicated to providing the highest quality peptides that empower our clients to push the boundaries.

Unparalleled Quality

Our proprietary processes and meticulous sourcing of premium materials ensure that every peptide we offer meets the most stringent standards.

Independently Verified

Every product undergoes extensive testing, both in-house and through independent, third-party laboratories.

Fast Shipping & Support

We provide fast and reliable shipping, using the best couriers and high-quality packaging materials to ensure that your peptides arrive promptly and in optimal condition.

More from Energy Support

View All